A Randomised, Open, Placebo Controlled, Two-way Crossover Phase I Study in Type 2 Diabetes Mellitus Patients Treated With Metformin to Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656.
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2010
At a glance
- Drugs AZD 1656; Gemfibrozil
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 14 Jun 2010 Actual patient number (19) added as reported by ClinicalTrials.gov.
- 26 May 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2010 New trial record